Combining the wearables tech and AI-based analytics to prevent chronic cardiac diseases including arrhythmia, stroke, and hypertension

Sign up today and learn more about HUINNO Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About HUINNO Stock

HUINNO, founded in 2014, is a 500 Startups and venture-backed digital healthcare company with offices in Boston, New York, and Seoul. They are focusing on changing the way clinicians and patients manage chronic cardiac diseases using their proprietary breakthrough technologies in wearable devices and AI-based analytics cloud. HUINNO's clinically-tested platform is capable of continuously measuring a variety of vital health data in real-time with clinical-grade accuracy. -- By combining wrist and chest wearables with artificial intelligence, HUINNO provides superior real-time cardiac biometrics including ECG, Blood Pressure, Heart Rate, SpO2. Delivering healthcare providers with an effective remote patient monitoring solution that drastically improves chronic cardiac disease prevention while lowering readmission rate compared to the existing standard of care. HUINNO's app and cloud-based eco-system also allow consumers to access longitudinal trend analysis of blood pressure, medication compliance, and nutritional / exercise habits as well as coaching and medication titration from HUINNO's clinical experts.

Funding History

August 2019$8.3B
March 2020$4.0M
December 2021$43.5B


Head of Research Lab

Jinbuhm Kim

Founder & CEO

Yeongjoon Gil

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: